These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 11914549)

  • 1. Detection of microembolic signals in patients with neuropsychiatric lupus erythematosus.
    Kumral E; Evyapan D; Keser G; Kabasakal Y; Oksel F; Aksu K; Balkir K
    Eur Neurol; 2002; 47(3):131-5. PubMed ID: 11914549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies.
    Afeltra A; Garzia P; Mitterhofer AP; Vadacca M; Galluzzo S; Del Porto F; Finamore L; Pascucci S; Gasparini M; Laganà B; Caccavo D; Ferri GM; Amoroso A; Francia A
    Neurology; 2003 Jul; 61(1):108-10. PubMed ID: 12847168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India.
    Singh S; Gupta MK; Ahluwalia J; Singh P; Malhi P
    Rheumatol Int; 2009 Oct; 29(12):1455-61. PubMed ID: 19306097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microembolic signals in patients with systemic lupus erythematosus.
    Azarpazhooh MR; Mokhber N; Orouji E; Chambers BR; Hatef MR; Rezaieyazdi Z; Sedighi S; Foroghipoor M; Velayati A; Gharavi MM
    Can J Neurol Sci; 2010 May; 37(3):371-5. PubMed ID: 20481272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
    Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
    PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of circulating anti-N-methyl-
    Tay SH; Fairhurst AM; Mak A
    Autoimmun Rev; 2017 Feb; 16(2):114-122. PubMed ID: 27988431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of anticardiolipin antibody in patients with systemic lupus erythematosus and its association with clinical manifestations.
    Basiri Z; Gholyaf M; Faridnia M; Nadi E; Bairanvand M
    Acta Med Iran; 2013; 51(1):35-40. PubMed ID: 23456582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.
    Mikdashi J; Handwerger B
    Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic criteria for systemic lupus erythematosus: a critical review.
    Yu C; Gershwin ME; Chang C
    J Autoimmun; 2014; 48-49():10-3. PubMed ID: 24461385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus.
    Taraborelli M; Lazzaroni MG; Martinazzi N; Fredi M; Cavazzana I; Franceschini F; Tincani A
    Reumatismo; 2016 Dec; 68(3):137-143. PubMed ID: 27981815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus.
    Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A
    PLoS One; 2015; 10(3):e0119911. PubMed ID: 25781014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus.
    Hanly JG; Robichaud J; Fisk JD
    J Rheumatol; 2006 Aug; 33(8):1553-8. PubMed ID: 16881112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of antiphospholipid autoantibodies in the cognitive deficits of patients with systemic lupus erythematosus.
    Coín MA; Vilar-López R; Peralta-Ramírez I; Hidalgo-Ruzzante N; Callejas-Rubio JL; Ortego-Centeno N; Pérez-García M
    Lupus; 2015 Jul; 24(8):875-9. PubMed ID: 25697771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain unidentified bright objects ("UBO") in systemic lupus erythematosus: sometimes they come back. A study of microembolism by cMRI and Transcranial Doppler ultrasound.
    Bortoluzzi A; Padovan M; Azzini C; De Vito A; Trotta F; Govoni M
    Lupus; 2016 Feb; 25(2):193-8. PubMed ID: 26405021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M; Duzgun N; Tunc SE; Tutkak H
    Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of aPS/PT antibodies in neuropsychiatric lupus and cardiovascular complications of systemic lupus erythematosus.
    Ramirez GA; Canti V; Del Rosso S; Erra R; Moiola L; Magnoni M; Bozzolo EP; Manfredi AA; Rovere-Querini P
    Autoimmunity; 2020 Feb; 53(1):21-27. PubMed ID: 31782311
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies.
    Golstein M; Meyer O; Bourgeois P; Palazzo E; Nicaise P; Labarre C; Kahn MF
    Clin Exp Rheumatol; 1993; 11(4):373-9. PubMed ID: 8403581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus.
    Song J; Park YB; Lee WK; Lee KH; Lee SK
    Rheumatol Int; 2000 Dec; 20(1):1-7. PubMed ID: 11149654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus.
    Magro-Checa C; Schaarenburg RA; Beaart HJ; Huizinga TW; Steup-Beekman GM; Trouw LA
    Lupus; 2016 Jul; 25(8):878-88. PubMed ID: 27252265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-dsDNA titre in female systemic lupus erythematosus patients: relation to disease manifestations, damage and antiphospholipid antibodies.
    Gheita TA; Abaza NM; Hammam N; Mohamed AAA; El-Gazzar II; Eissa AH
    Lupus; 2018 Jun; 27(7):1081-1087. PubMed ID: 29460701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.